Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis

OBJECTIVES: Nerve growth factor (NGF) has emerged as a key driver of pain in osteoarthritis (OA) and antibodies to NGF are potent analgesics in human disease. Here, we validate a novel vaccine strategy to generate anti-NGF antibodies for reversal of pain behaviour in a surgical model of OA. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: von Loga, Isabell S, El-Turabi, Aadil, Jostins, Luke, Miotla-Zarebska, Jadwiga, Mackay-Alderson, Jennifer, Zeltins, Andris, Parisi, Ida, Bachmann, Martin F, Vincent, Tonia L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Osteoarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517802/
https://www.ncbi.nlm.nih.gov/pubmed/30862648
http://dx.doi.org/10.1136/annrheumdis-2018-214489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517802/
https://www.ncbi.nlm.nih.gov/pubmed/30862648
http://dx.doi.org/10.1136/annrheumdis-2018-214489

Ejemplares similares